Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
CIMA — Centro de Información de Medicamentos · Spain
- Updated
- Not provided for this source record
- Synchronized
- Oct 2, 2026
Medicine · Spain
EXELON 13,3 mg/24 H PARCHE TRANSDERMICO
Patch
Home Med Cabinet
Updated · Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) — Not provided for this source record
Synchronized
At a glance
- Active ingredient
- RIVASTIGMINA — 13.3 mg/24 h
- Pharmaceutical form Home Med Cabinet grouping
- Patch
- Availability in Spain
- 1 of 2 packs marketed
Packs
EXELON 13,3 mg/24 H PARCHE TRANSDERMICO 60 sobres
60 pcs
National code
Not marketed697755Strength of this pack 13.3 mg
EXELON 13,3 mg/24 H PARCHE TRANSDERMICO 60 (2 x 30) parches
60 pcs
National code
Marketed728198Strength of this pack 13.3 mg
“Marketed” means the authority records the pack as placed on the market. It is not a statement about pharmacy stock.
Official documents
Documents open on the authority’s own site. Home Med Cabinet links to them and hosts no copy.
- Official
Opens on the authority’s own site
- Official
Summary of product characteristics
Opens on the authority’s own site
Registration
- Registration number
- 198066029Official data
- Marketing authorisation holder
- NOVARTIS EUROPHARM LIMITEDOfficial data
- Authorised
- Apr 24, 2013Official data
- Authority form code
- 104Official data
Classification
ATC classification is not published here yet
Publication rights for ATC codes and labels are still under review, and no classification is inferred for this record.